Oncotarget

Reviews:

Equine infectious anemia virus in China

Hua-Nan Wang, Dan Rao, Xian-Qiu Fu, Ming-Ming Hu _ and Jian-Guo Dong

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:1356-1364. https://doi.org/10.18632/oncotarget.20381

Metrics: PDF 1528 views  |   HTML 2730 views  |   ?  


Abstract

Hua-Nan Wang1,*, Dan Rao2,3,*, Xian-Qiu Fu5, Ming-Ming Hu4,* and Jian-Guo Dong2,*

1Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, China

2School of Animal Husbandry and Medical Engineering, Xinyang Agriculture and Forestry University, Xinyang, China

3Guangdong Key Laboratory of Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China

4Shanxi Provincial Animal Disease Control Center, Taiyuan, China

5The First Affiliated Hospital of Harbin Medical University, Harbin, China

*These authors contributed equally to this work

Correspondence to:

Ming-Ming Hu, email: [email protected]

Jian-Guo Dong, email: [email protected]

Keywords: equine infectious anemia virus, epidemic, vaccine, virulence, immune response

Received: June 20, 2017     Accepted: August 09, 2017     Published: August 21, 2017

ABSTRACT

Equine infectious anemia is an equine disease caused by equine infectious anemia virus, which was first reported in 1840. Equine infectious anemia virus research in China started in the 1960s, focusing on etiology, pathology, diagnosis, and immunology. Notably, in 1978 an attenuated vaccine was successfully developed for equine infectious anemia virus, effectively preventing equine infectious anemia virus in China. This article will review equine infectious anemia virus in China, including past and recent research, and commemorate scientists who have made great contributions to equine infectious anemia virus prevention.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20381